TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage.

about

TP53 mutation predicts the poor prognosis of non-Hodgkin lymphomas: Evidence from a meta-analysis.PARP1 expression in mantle cell lymphoma: the utility of PARP1 immunohistochemistry and its relationship with markers of DNA damage.

P2860

Q36332053-472C30C8-648F-41CE-AD41-416F4E33422E Q39142155-EC88DFB8-62A0-4BC6-A308-7DE41076956B

P2860

TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage.

Item

http://www.wikidata.org/entity/Q44418379

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

TP53 mutation is not an indepe ...... ll lymphoma at advanced stage.

@en

TP53 mutation is not an indepe ...... ll lymphoma at advanced stage.

@nl

type

Item

label

TP53 mutation is not an indepe ...... ll lymphoma at advanced stage.

@en

TP53 mutation is not an indepe ...... ll lymphoma at advanced stage.

@nl

prefLabel

TP53 mutation is not an indepe ...... ll lymphoma at advanced stage.

@en

TP53 mutation is not an indepe ...... ll lymphoma at advanced stage.

@nl

P1476

TP53 mutation is not an indepe ...... ll lymphoma at advanced stage.

@en

P2093

Cheng Fang

http://www.w3.org/2001/XMLSchema#string

Dan-Xia Zhu

http://www.w3.org/2001/XMLSchema#string

Hua-Jie Dong

http://www.w3.org/2001/XMLSchema#string

Jian-Yong Li

http://www.w3.org/2001/XMLSchema#string

Lei Fan

http://www.w3.org/2001/XMLSchema#string

Li-Tao Zhou

http://www.w3.org/2001/XMLSchema#string

Wei Xu

http://www.w3.org/2001/XMLSchema#string

Yin-Hua Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Gene silencing in cancer in association with promoter hypermethylation

Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.

Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.

Dissecting p53-dependent apoptosis.

Molecular genetic characterization reveals new subsets of mantle cell lymphoma.

Molecular outcome prediction in mantle cell lymphoma.

P2888

s12032-011-0096-5

P304

2166-2173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-011-0096-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22057359

http://www.w3.org/2001/XMLSchema#string

TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage.

about

P2860

P2860

TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698